Register                                       Already Registered?  Log In

Deaths from drug overdoses have increased in Wisconsin driven by the explosion in addiction to prescription painkillers and heroin.  This education is meant to help providers make informed decisions about acute and chronic pain while encouraging the implementation of best practices for responsible prescribing.  Approved in Wisconsin, Iowa, and many other states.  Contact IPMA if you have any questions.

Target Learners

This activity is designed for clinicians who prescribe controlled substances.

Registration Fees

$60

Credit

This activity was planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME).  The Interstate Postgraduate Medical Association is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designations

The Interstate Postgraduate Medical Association designates this enduring activity for a maximum 2.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 3 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

This education meets the Wisconsin Medical Examining Board's emergency rule relating to continuing medical education on its opioid prescribing guideline.

   Commercial Support

None

  Method of Participation

Learner pays the appropriate fee for participating in and receiving credit for this online educational activity.  In order to obtain credit for participating in this activity during the period of April 1, 2017 through April 1, 2018, participants must:

  1. Read the educational objectives and disclosure statements.
  2. View the four video sessions on Responsible Opioid Prescribing.
  3. Complete the post-assessment and receive a score of 100%.
  4. Submit the online evaluation and redeem number of credits.
  5. Printable PDF certificate will be generated.

Learning Objectives

At the completion of this activity, you will be able to:

  • Order and interpret urine drug tests for monitoring appropriate opioid use
  • Define the role of a controlled substances agreement in opioid prescribing
  • Perform a risk assessment on a patient for whom opioids are being considered
  • Identify factors that increase and decrease mortality in patients being prescribed opioids for pain
  • Gain references and resources to further study best opioid prescribing practices

Faculty 

Karen Hulbert, MD
Associate Professor
Department of Family & Community Medicine
Medical College of Wisconsin

Cheri L. Olson, MD
Associate Director
Mayo Graduate School of Medicine
La Crosse-Mayo Family Medicine Residency

  Disclosure Information

As a provider dedicated to independent education and accredited by the ACCME, IPMA must ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. It is the policy of IPMA to require disclosure of the existence of any significant financial interest or other relationship a faculty member, planner, or a sponsor has with either the commercial supporter of this activity or the manufacturer(s) of any commercial product(s) discussed in an educational presentation:

Faculty
Karen Hulbert, MD, has no relevant financial relationships to disclose.
Cheri L. Olson, MD, has no relevant financial relationships to disclose.

Content Reviewers
Rodney Erickson, MD has no relevant financial relationships to disclose.
Colleen Nichols, MD has no relevant financial relationships to disclose.

Staff
Mary W. Ales, CCMEP, FACEHP has no relevant financial relationships to disclose.
Heidi Ness, has no relevant financial relationships to disclose.
Kate Nisbet, MBA, has no relevant financial relationships to disclose.

 

Disclaimer

The opinions expressed in the enduring educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Privacy Policy

At IPMA, we care about providing you with tools and information to manage and protect your online privacy. IPMA retains records solely for keeping records in accordance with ACCME policies. We will not share your information with any other organizations. We will keep you informed of our CME activities. Please e-mail cmehelp@ipmameded.org if you do not want to receive any communications from us.

Copyright

© Copyright 2017 by IPMA. This also contains material copyrighted by third parties.

Register